On 30 & 31 May 2019, New York (USA) hosted the BioTech Pharma Summit: Inhalation & Respiratory Drug Delivery 2019 (IRDD) conference at the Crowne Plaza Times Square. The IRDD Summit is designed for senior industry experts that will showcase new trends in aerosol science and the future directions of inhalation drug delivery research. Further discussion focusses on the regulatory pathways for inhaled therapies and challenges of bringing respiratory products to market. The agenda featured key case studies on the latest trends in inhalation devices, from inhaled insulin to gene therapy.

Over 100+ delegates representing global pharmaceutical organisations, leading biotech companies and internationally renowned academic institutions will be joining the Inhalation & Respiratory Drug Delivery 2019

The global pulmonary drug delivery market is projected to reach USD 52.37 Billion by 2021 from USD 36.10 Billion in 2016, at a CAGR of 6.5% during the forecast period. Growth in this market is mainly driven by increasing preference of pulmonary route of drug delivery, increasing technological developments in the form of smart/digital inhalers and rising incidences of respiratory diseases such as COPD, asthma, and cystic fibrosis.

Over 20+ presentations and case studies focused on the key issues in inhalation and respiratory drug delivery.

The BioTech Pharma Summit: Inhalation & Respiratory Drug Delivery 2019 will focus on the challenges of bringing respiratory products to market and innovative aerosol science, including modelling and toxicology. Presentations will also feature key case studies on the latest trends in inhalation devices, from inhaled insulin to gene therapy to overcome lung and pulmonary conditions, such as COPD, asthma and cystic fibrosis.

Key Practical Points

  • Novel technologies for pulmonary & nasal delivery
  • Innovative development of inhalation devices
  • Digital health combination products
  • Analytical tools for inhaled medicines
  • Challenges of bringing inhalation and respiratory drug delivery products to market
  • Regulatory updates in the global respiratory market
  • The challenges of developing inhalation devices
  • Alternative therapeutic fields
  • Dry-powder inhalers (DPIs) and Metered-dose inhalers (MDIs)
  • Routes to controlling aerosol response
  • Characterizing aerosol dynamics
  • Model validation
  • Future directions in inhalation and respiratory drug delivery research
  • Regulatory pathways for inhaled therapies
  • Challenges of developing a generic inhaled product

Key Speakers

John Patton

Chairman & Chief Scientific Officer at Dance Biopharm

Yu-Feng Yvonne Chan

Director, Center for Digital Health at Mount Sinai

Larry Brown

Executive Vice President of R&D and CSO, Noveome Biotherapeutics

Kristen Merriman

Director of Respiratory Care Services, Stanford University

Thanks to our Sponsors


Hotel Venue

Crowne Plaza Times Square

Experience New York on Your Terms

The perfect getaway in the heart of Manhattan
This is New York City. Crowne Plaza Times Square is perfectly located in the heart of midtown Manhattan, situated directly on Broadway between 48th and 49th Streets at the door step to Times Square. Crowne Plaza Times Square provides you the power to choose when and how you access all that New York has to offer. Just beyond their front doors are headquarters of Fortune 500 companies, and the best shopping, theater and historical attractions in the city. Times Square, Central Park, Rockefeller Center, Radio City Music Hall and the greatest musical theater anywhere in the world aren’t just a cab ride away — they’re mere steps away.

The hotel has 25,000 square feet (2322 square meters) of private event space onsite, with 28 meeting rooms, and 2 Ballrooms, including our 6,750 Sq. ft. Broadway Ballroom with 20’ ceilings. The hotel can accommodate “meet and feed” groups up to 450 guests with abundant natural daylight in our Atrium pre-function space.


Promo Video